Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03307785
Title Study of Niraparib or Carboplatin-Paclitaxel in Combination With TSR-042
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

Advanced Solid Tumor

Therapies

Carboplatin + Dostarlimab-gxly + Paclitaxel

Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
GSK Investigational Site Scottsdale Arizona 85258 United States Details
GSK Investigational Site Encinitas California 92024 United States Details
GSK Investigational Site San Marcos California 92069 United States Details
GSK Investigational Site Sarasota Florida 34232 United States Details
GSK Investigational Site Canton Ohio 44718 United States Details
GSK Investigational Site Cleveland Ohio 44106 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field